Non-small-cell lung cancer and breast carcinoma: chemotherapy and beyond.

  title={Non-small-cell lung cancer and breast carcinoma: chemotherapy and beyond.},
  author={Sarita Dubey and Jill M. Siegfried and Anne M. Traynor},
  journal={The Lancet. Oncology},
  volume={7 5},
Early screening, adjuvant and sequential systemic treatment, and hormonal therapy have benefits in treatment of breast cancer. Management of non-small-cell lung cancer (NSCLC) is progressing and will hopefully follow in the same footsteps as that of breast cancer. Only recently have clinical trials established adjuvant treatment as the standard of care in lung cancer. A growing number of effective cytotoxic and targeted agents have resulted in increased survival when used as sequential… CONTINUE READING